Libin Ren
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
- Acute Myocardial Infarction Research
- Blood Pressure and Hypertension Studies
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Heart Failure Treatment and Management 1
- Cardiovascular Health and Disease Prevention 1
- Blood Pressure and Hypertension Studies 1
- Cardiac Valve Diseases and Treatments 1
- Cardiovascular Function and Risk Factors 1
- Co-authors
- Hongliang Cong (4 shared papers)Wei Qi (3 shared papers)Jingxia Zhang (3 shared papers)Le Wang (2 shared papers)Ao Wei (2 shared papers)Yuecheng Hu (3 shared papers)Hua Yang (2 shared papers)Jinghan Xu (1 shared paper)
- Journals
- Frontiers in Cardiovascular Medicine (3 papers)Risk Management and Healthcare Policy (1 paper)Cardiovascular Diabetology (1 paper)Angiology (1 paper)
- Partner nations
- China
In The Last Decade
Libin Ren
6 papers receiving 299 citations
Libin Ren's Hit Papers
Peers
Comparison fields: 5 of 35
- Endocrinology, Diabetes and Metabolism 109
- Cardiology and Cardiovascular Medicine 72
- Nephrology 8
- Epidemiology 32
- Radiology, Nuclear Medicine and Imaging 14
Countries citing papers authored by Libin Ren
This map shows the geographic impact of Libin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libin Ren more than expected).
Fields of papers citing papers by Libin Ren
This network shows the impact of papers produced by Libin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libin Ren. The network helps show where Libin Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Libin Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome Hit paper breakdown → | 2020 | 267 |
| 2 | 2021 | 14 | |
| 3 | 2021 | 8 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 4 | |
| 6 | 2022 | 4 |
About Libin Ren
Libin Ren is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Cancer Research and Infectious Diseases, having authored 6 papers that have together received 302 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Heart Failure Treatment and Management (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Cardiovascular Health and Disease Prevention (1 paper), Blood Pressure and Hypertension Studies (1 paper), Cardiac Valve Diseases and Treatments (1 paper), Cardiovascular Function and Risk Factors (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (109 citations), Cardiology and Cardiovascular Medicine (72 citations), Nephrology (8 citations), Epidemiology (32 citations) and Radiology, Nuclear Medicine and Imaging (14 citations). Libin Ren has collaborated with scholars based in China. Frequent co-authors include Hongliang Cong, Wei Qi, Jingxia Zhang, Le Wang, Ao Wei, Yuecheng Hu, Hua Yang, Jinghan Xu, Rui Zhang and Wenyu Li. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Risk Management and Healthcare Policy, Cardiovascular Diabetology and Angiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.